McDermott + Bull has successfully placed Scott Durbin as Chief Executive Officer at illumiSonics. In this role, Scott will partner with the Board and leadership team to cultivate the strategic vision, streamline the go-to-market strategy, strengthen their world-class...
McDermott + Bull has successfully placed Andy Shashlo as Chief Executive Officer of ColorCoat, Inc. Andy will focus on the growth and operational improvement of the company while working closely with the organization’s Board of Directors and President. He will...
McDermott + Bull has successfully placed Joshua (Josh) Woolley as Vice President of Clinical Affairs and Regulatory at Aria CV. Josh will be responsible for launching the company’s early feasibility study and leading ongoing engagements with the FDA to drive product...
McDermott + Bull Partner Ken Dropiewski interviews H.I.G. Capital Managing Director Gwen Watanabe in his series, Investor Insights in Life Sciences + MedTech. In these conversations, they discuss H.I.G. Capital investments and medtech ventures in 2023. SEE MORE...
A CONVERSATION WITH RENOWNED VASCULAR SURGEON, DR. FRANK J. VEITH As one of America’s most celebrated surgeons, Dr. Frank Veith’s career was anything but conventional – he’s worked undercover for the CIA, attempted to make Vascular Surgery an independent specialty,...
MEDTECH + LIFE SCIENCES OUTLOOK IN 2023 2022 was an interesting year, to say the least. It was the tale of two markets. After the extremely volatile years of 2020 and 2021, no one could have predicted the sheer amount of momentum that lay ahead in 2022. The economy...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
